Hu Nan, Wang Chaoyu, Zhang Tongwu, Su Hua, Liu Huaitian, Yang Howard H, Giffen Carol, Hu Ying, Taylor Philip R, Goldstein Alisa M
Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD 20892, USA.
Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD 20892, USA.
Cancers (Basel). 2022 Oct 13;14(20):5001. doi: 10.3390/cancers14205001.
BACKGROUND: Human Cub and Sushi Multiple Domains 1 (CSMD1) is a novel candidate tumor-suppressor gene that codes for multiple domains, including complement regulatory and adhesion proteins, and has recently been shown to have alterations in multiple cancers. We investigated CSMD1 in esophageal squamous cell carcinoma (ESCC) by performing an integrated analysis on somatic copy number alterations (CNAs), including copy-number gain or loss, allelic imbalance (AI), loss of heterozygosity (LOH), and the expressions of mRNA and its target miRNAs on specimens from the same patients with ESCC. RESULTS: (i) Two-thirds of ESCC patients had all three types of alterations studied-somatic DNA alterations in 70%, and abnormal expressions of CSMD1 RNA in 69% and in target miRNAs in 66%; patterns among these alterations were complex. (ii) In total, 97% of 888 CSMD1 SNPs studied showed somatic DNA alterations, with most located near exons 4-11, 24-25, 39-40, 55-56, and 69-70. (iii) In total, 68% of SNPs with a CNA were correlated with expression of CSMD1. (iv) A total of 33 correlations between non-coding SNPs and expression of CSMD1 target miRs were found. CONCLUSIONS: Our results indicate that the gene may play a role in ESCC through complex patterns of DNA alterations and RNA and miRNA expressions. Alterations in some somatic SNPs in non-coding regions of appear to influence expression of this gene and its target miRNAs.
背景:人Cub和寿司多结构域蛋白1(CSMD1)是一种新型候选肿瘤抑制基因,编码包括补体调节蛋白和粘附蛋白在内的多个结构域,最近已证实在多种癌症中存在改变。我们通过对体细胞拷贝数改变(CNA)进行综合分析,包括拷贝数增加或减少、等位基因失衡(AI)、杂合性缺失(LOH)以及来自同一食管癌(ESCC)患者标本中mRNA及其靶标miRNA的表达,来研究CSMD1在食管鳞状细胞癌中的情况。 结果:(i)三分之二的ESCC患者存在所研究的所有三种类型的改变——70%的患者存在体细胞DNA改变,69%的患者CSMD1 RNA表达异常,66%的患者靶标miRNA表达异常;这些改变之间的模式很复杂。(ii)在总共研究的888个CSMD1单核苷酸多态性(SNP)中,97%显示体细胞DNA改变,大多数位于外显子4 - 11、24 - 25、39 - 40、55 - 56和69 - 70附近。(iii)总共68%的具有CNA的SNP与CSMD1的表达相关。(iv)总共发现了33个非编码SNP与CSMD1靶标miR表达之间的相关性。 结论:我们的结果表明,该基因可能通过复杂的DNA改变模式以及RNA和miRNA表达在ESCC中发挥作用。CSMD1非编码区某些体细胞SNP的改变似乎会影响该基因及其靶标miRNA的表达。
Cancer Cell Int. 2005-9-9
Genomics Proteomics Bioinformatics. 2015-8
Exp Hematol Oncol. 2018-5-2
CA Cancer J Clin. 2016-1-25
Nat Med. 2015-8